Vanessa Kerry is the new WHO envoy for health resilience. What's on her to-do list? - NPR

Take a look through some of the notable data presentations at this year's ESMO Congress. Related to this articleOctober 14th, 2026Delayed diagnosis and skipped nodal staging worsen penile cancer outcomes, according to Luis G. Medina, MD. Read moreOctober 20th, 2026The investigational HIF-2α inhibitor casdatifan demonstrated antitumor activity as monotherapy and in combination regimens across the ARC-20 platform study. Read moreOctober 19th, 2026The agency issued a PDUFA target action date of June 14, 2027. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, reviews evidence on ARPI dose reduction in prostate cancer and discusses monitoring treatment response, tolerability, and dose reescalation. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, discusses managing ARPI-related fatigue through dose adjustments, patient monitoring, and strategies to maintain treatment adherence. Read moreOctober 16th, 2026Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.

Serum urate monitoring and urate-lowering therapy prescribing increased among patients with gout after their first nephrology visit, and gout-related outcomes improved during subsequent follow-up, according to a retrospective study being presented during American Society of Nephrology (ASN) Kidney Week 2026. Gout is common among patients with CKD, but managing the condition can be challenging in those with multiple comorbidities. Although most treatment of gout occurs in primary care settings, relatively little is known about changes in treatment patterns and outcomes after patients transition to nephrology care. To address this knowledge gap, investigators used the Optum Clinformatics Data Mart database to analyze insurance claims from 2,765 adults with gout who had an initial nephrology visit between 2016 and 2025. Patients were required to have continuous insurance enrollment for 1 year before and 2 years after their first nephrology visit. Changes in gout management and clinical outcomes were assessed in successive 6-month intervals. The study population had a mean age of 73 years. Most were men (64%) and had CKD (84%).

It is a dietary staple found in sushi, rice wraps and ramen toppings. Commonly known as nori in Japan and gim in Korea, red seaweed is especially popular across Asia. Yet, despite its widespread consumption, many of its nutritional benefits remain poorly understood. Now, research led by Hokkaido University scientists has discovered that digestion of a particular red alga releases a peptide, or a small fragment of protein, with potential benefits for blood glucose control and diabetes prevention. The study was published in Food Bioscience.